Introduction apo B is synthesized in both liver and intestine and is an important structural constituent of several classes of lipoproteins, including liver-derived VLDL and its breakdown products IDL and LDL and intestinally derived chylomicrons ( 1) . In humans, mature liver-derived apo B is 4,536 amino acids in length (B-100), whereas intestinal apo B is roughly half the size and includes only the amino-terminal 2,152 residues (B-48) (2, 3) . B-100 and B-48 are encoded by a single 43-kb gene containing 29 exons (4) . The mechanism for production of two proteins from a single gene involves editing of the primary transcript with the introduction of a stop at codon 2,153 (5, 6) . In humans this occurs exclusively in the intestine, whereas in rodents it also occurs in the liver (7) .
The importance of apo B in human physiology has been amply documented. Plasma levels of apo B are an important risk factor for coronary heart disease (8, 9) , and apo B is the ligand for receptor-mediated removal of LDL particles from the circulation (1) . Human mutations in the putative LDL receptor binding region of apo B delay LDL clearance and cause increased plasma LDL levels (10) . apo B is also required for secretion of lipoprotein particles from the liver and intestine. Humans with abetalipoproteinemia, who degrade apo B intracellularly because they fail to properly lipidate newly synthesized apo B due to homozygosity for genetic defects in the microsomal triglyceride transfer protein (11) (12) (13) , have little to no circulating VLDL, IDL, LDL, or chylomicrons (1) . A similar phenotype is observed in humans with homozygous hypobetalipoproteinemia, due to mutations in the apo B gene that preclude synthesis of the full length protein (1, 14) . The inability to secrete intestinal apo B in abetalipoproteinemia and homozygous hypobetalipoproteinemia leads to malabsorption of fats causing steattorrhea and failure to thrive and fat-soluble vitamin deficiency causing ataxia, retinitis pigmentosa, and an anemia characterized by acanthocytosis ( 1). Heterozygotes for hypobetalipoproteinemia are estimated to be 1/500-1/1,000 of individuals in the population (14) . These individuals are asymptomatic but have -30-50% of normal plasma apo B and LDL cholesterol levels (14) .
To better understand the role of apo B in the body, we now report the creation by homologous recombination in Southern blot analysis. ES cell DNA was isolated by digesting cells in lysis buffer (1% SDS, 100 mM NaCl, 10 mM Tris, pH 7.5, and 1 mM EDTA) with 625 kig/ml of proteinase K at 550C overnight. Genomic DNA was spooled after precipitation in two vol of 100% ethanol.
For Southern blot analysis, 5-10 og of genomic DNA was digested with EcoRI and analyzed as described previously (20) . An external apo B probe 3' to the 2.5-kb BamHI-XbaI fragment and a probe containing the neo gene ( Fig. 1 , line 3) were used for screening both DNA samples from ES cells and mouse tail tips.
Generation and genotypic analysis ofchimeric and mutant mice. ES cells containing a copy of the null apo B allele were expanded and microinjected into 3.5-d-old host blastocysts derived from C57BL/6J mice. The blastocysts were then surgically implanted into the uterine horn of surrogate mothers as described previously (21) . All resulting chimeric mice were crossed to C57BL/6J mice and germ line transmission was scored by coat pigment. Fl heterozygotes were identified by Southern blot analysis of tail tip DNA. Tail tip DNA was prepared by rocking tail tips in lysis buffer ( 10 mM EDTA, 0.5% n-lauroylsarcosine, 0.1 M Tris-HCl, pH 8.0, 0.2 M NaCl, 4 M urea) with 1 mg/ml of proteinase K at 55°C overnight. Tail tip DNA was spooled and subjected to Southern blot analysis as described for ES cell DNA. Positive F1 heterozygotes were backcrossed to C57BL/6J to expand the colony and resulting N2 progeny were intercrossed to generate homozygotes.
Genotypic and phenotypic analysis ofmutant embryos. Timed pregnancies were set up for both heterozygous intercrosses and backcrosses. (25) . Both fractions of lipoproteins (d > 1.006 grams/ml and HDL) were subjected to cholesterol analysis. LDL cholesterol (LDL-C) is the difference between d > 1.006 grams/ml and HDL, and VLDL cholesterol (VLDL-C) is the difference between total cholesterol and d > 1.006 grams/ml. In the HDL fraction, free cholesterol and total cholesterol were measured by gas chromatography with coprostanol as an internal standard (25) . HDL cholesterol ester (CE) was the difference between free cholesterol and total cholesterol.
For FPLC size fractionation, 200 ,l of pooled and filtered mouse plasma was injected onto two Superose-6 columns in tandem (Pharmacia LKB Biotechnology, Piscataway, NJ) and eluted at a constant flow rate of 0.3 ml/min with 1 mM EDTA and 0.15 M NaCl (26) .
Fractions of 0.5 ml were collected and cholesterol concentrations were measured enzymatically.
In vivo HDL turnover studies. HDL turnover studies were carried out using doubly labeled HDL as described previously (25), except mouse A-I was purified from pooled plasma samples of control mice and then subjected to iodination. HDL-CE was labeled with 3H-cholesteryl oleoyl ether previously dissolved in intralipid and transferred into HDL by cholesteryl ester transfer protein from d > 1.25 grams/ml rabbit plasma. Before injection, 2-4 ig of '25I-mouse A-I (sp act = 200 cpm/ng) was mixed with mouse HDL labeled with 3H-cholesteryl oleoyl ether (100,000-200,000 dpm). Before experiments, blood was drawn from fasted mice for measurements of HDL cholesterol and apo A-I levels. Mice were injected in the femoral vein with doubly labeled HDL.
Blood (100 ILI) was taken at 10 min, 90 min, 3 h, 8 h, and 24 h. Plasma (20 Ml) from each time point was counted in a gamma counter for the radioactivity of '25I-apo A-I. Another aliquot of plasma sample (40 ,1) was extracted with hexane and the radioactivity of 3H-cholesteryl oleoly ether was measured in a liquid scintillation counter. Fractional catabolic rates (FCRs) for apo A-I and HDL-CE were calculated from the plasma decay curves of '25I-apo A-I and 3H-cholesteryl oleoyl ether assuming a two-pool model as in the Matthews method (27) .
Western blot analysis. Mouse plasma samples were diluted with 0.9% NaCl, added to equal volume of 2x Laemmli buffer, and boiled for 5 min before SDS-PAGE (28) . For apo B detection, 10 Ml of plasma was separated in 5% separating/4% stacking gels. For apo A-I detection, 1 1d of plasma was separated in 10% separating/5% stacking gels. For apo A-I quantification, serial dilutions of mouse plasma with known apo A-I concentration were used as standards. Proteins were transferred from SDS-PAGE to nitrocellulose membrane as described (29) . Rabbit anti-rat apo B antibody crossreacting with mouse apo B (gift of Dr. David Usher, University of Delware, Newark, DE) and rabbit antimouse apo A-I antibody were used. Reactions between apolipoproteins and antibodies were detected by ECL reagent (Amersham Corp., Arlington Heights, IL) and exposed to x-ray films. For quantification, autoradiograms were scanned with a densitometer.
Northern blot analysis. Both liver and intestinal tissues were removed from heterozygotes and wild-type littermates and RNA was isolated using the guanidinium thiocyanate method (30) . Total cellular RNA of 10 j.g from each tissue was separated on 6% formaldehyde/ agarose gels and then transferred to a nylon membrane. Hybridizations were carried out as described previously (24) . For apo B or apo A-I mRNA detection, 0.8 and 1.5% agarose gels were used, respectively. A human cDNA probe containing 6 kb of human apo B sequences in exon 26 (24) and a mouse apo A-I cDNA riboprobe (25) were used to detect apo B and apo A-I mRNA, respectively. A mouse P3-actin riboprobe (Ambion Inc., Austin, TX) was used in each experiment to normalize the loading of RNA samples. For quantification, autoradiograms were scanned with a densitometer.
Intestinal cholesterol absorption. Intestinal cholesterol absorption was determined in six heterozygotes and eight wild-type littermates maintained on a chow diet by the dual-label technique described (31, 32) . 3H-cholesterol and "4C-cholesterol in toluene solvent (Amersham Corp.) were dried under nitrogen gas and then resuspended in ethanol and followed by dilution to a final concentration of 2.5% with 0.9% NaCl and skim milk, respectively. After an 8-h fast, mice were intravenously injected with 10 A Ci of 3H-cholesterol (in 0.9% NaCl) and fed with 10 uCi of '4C-cholesterol (in skim milk) as an intragastric bolus. Mice were bled at 21, 39, 45, 62, and 69 h after administration of radiolabeled cholesterol and 60 ,u of plasma was counted in a liquid scintillation counter. The ratio of 14C-cholesterol to that of 3H-cholesterol was measured at each time point to determine the percentage of cholesterol absorbed.
Results
Creation of a mouse with a null apo B allele. We have targeted the apo B gene at the 5' end to create ES cells with a null mutation as shown in Fig. 1 . 500 neo resistant ES clones were screened and only one was a homologous integrant as shown in Fig. 2 A, lane 2. The mutant 5.5-kb fragment also hybridized to a probe containing the neo gene sequence (probe B, Fig. 1 , line 3) which confirmed the homologous recombination event (data not shown). 27 male chimeras were generated from microinjection of the positive ES clone. Seven of these chimeras gave agouti pups, but only one transmitted the null apo B allele through the germ line as shown in lane 2 of Fig. 2 B. This chimera bred infrequently and yielded small litter sizes when crossed with female C57BL/6J mice. To obtain sufficient numbers of heterozygotes for analysis, heterozygous mice (Fl) derived from chimera/C57BL/6J crosses were backcrossed to C57BL/6J mice and the resulting heterozygotes (N2) were used for analysis. In the course of breeding, it was noted that twothirds of the heterozygous apo B knockout male studs, derived from either Fl or N2 backcrosses, were sterile. Male studs were routinely tested for fertility at the age of 2 mo. Sterility was defined as failure to impregnate female C57BL/6J mice over a duration of 4 mo.
Transmission of the null apo B allele in heterozygous intercrosses and backcrosses. Fertile N2 heterozygotes were intercrossed and no live homozygotes were bor, as shown in Table   2154 A B C D Figure 2 . I. In the same cross, the ratio of heterozygotes to wild-type animals was 1.4, which is less than the expected ratio of 2. In backcrosses between F1 and N2 heterozygotes and C57BL/ 6J mice, there were also less than the expected numbers of heterozygous offspring (Table I ). The percentage of live heterozygous offspring from Fl backcrosses was 41% and from N2 backcrosses 33%, which both were significantly lower than the expected 50% (Table I ). These data indicate that homozygosity for an apo B null allele is an embryonic lethal in the mouse and suggest that there are also significant numbers of heterozygous apo B knockout animals dying in utero.
Gross morphological examination indicated abnormalities in live-born heterozygous mice. In the Fl, C57BL/ 6J backcross 1 of 130 heterozygotes was abnormal showing asymmetrical plagiocephaly characterized by a craniofacial osseous deformity with stenosis of the right orbit. In the N2, C57BL/6J backcross 1 heterozygote was stillborn and had neural dysraphism characterized by defective closure of the overlying cranium, and 9 of 53 live-born heterozygotes (17%) were noted to be hydrocephalic at weaning (3-4 wk old). These mice displayed varying degrees of hypoactivity, lethargy, and stupor. They all had enlargement and doming of the calvarium with variable separation of the cranial sutures. Sequential cross sections of the decalcified head demonstrated prominent dilatation of the lateral and third ventricles of the brain with associated marked, cerebral, cortical atrophy (Fig. 3) . In two animals, there was also a moderate amount of intraventricular hemorrhage.
Embryos from heterozygous intercrosses and backcrosses.
To determine the gestational age for embryonic lethality in homozygotes, we analyzed the genotypes of embryos from intercrosses by Southern blot (Fig. 2 C) or PCR analysis (Fig. 2  D) . Of 32 day 9 embryos 25% were wild-type, 50% heterozygous, 19% homozygous knockout, and 6% untypeable (Table  II) . All of the homozygous embryos were resorbed with the DNA diagnosis from the remaining visceral yolk sac. Of 25 embryos harvested between days 10 and 15, 32% were wildtype, 52% heterozygous knockout, and 16% untypeable (Table  II) . No homozygous apo B knockout were detected after day 10 .
To investigate whether heterozygous apo B knockout mice were dying in utero, embryos from heterozygous intercrosses and backcrosses were analyzed. As shown in Table II , in the intercrosses 10 of 29 heterozygous embryos had abnormalities which were of three general types: complete resorption with residual visceral yolk sac (3/10); partial resorption (2/10); and gross malformations (5/10). The malformations generally consisted of incomplete neural tube closure (Fig. 4) , except one embryo with three sets of limbs. The neural tube abnormalities included incomplete closure of the hind portion, mid portion, or entire head region, as well as partial or complete opening of the spinal canal.
Resorption and malformation were also observed in heterozygous embryos from backcrosses. At gestational days 9-11, 54% (15/28) of heterozygous embryos and 25% (8/32) of wild-type embryos were either resorbed or malformed (Table  II) . At gestational days 12-15, the 31% of heterozygous em- 39 and 38% decreases in HDL-C and 37 and 33% decreases in LDL-C on the two diets, respectively (Table III) .
HDL-CE and apo A-I turnover studies. Quantitatively the major contributor to reduced cholesterol levels in heterozygous apo B knockout mice was the HDL fraction. To evaluate the underlying metabolic mechanism, in vivo turnover studies with HDL doubly labeled with '25I-apo A-I and 3H-cholesteryl oleoyl ether were performed. After intravenous injection of labeled HDL, the disappearance of plasma radioactivity was measured and the FCRs of HDL-CE and apo A-I were calculated by the Matthews method (27) . Transport rates (TRs) for HDL-CE and apo A-I were calculated as the product of FCR and pool size reflected by the plasma concentration of HDL-CE and total (65%) (35%)
* Placenta were present but neither extraembryonic nor embryonic tissues were available for genotyping; these embryos were presumed abnormal.
Either resorbed embryos or embryos exhibiting gross malformations. § All six embryos were resorbed. 11 Six of the abnormal embryos were offspring of (+/-) females and two were offspring of (+/-) males. I Projected number of (+/+) and (+/-) mice reaching term presuming perinatal death of all abnormal embryos. figure. apo A-I, respectively. As shown in Table IV , there were no differences in the FCRs for HDL-CE or apo A-I between heterozygotes and wild-type littermates. In contrast, the TRs for HDL-CE and apo A-I in heterozygotes were -30 and 34% lower, respectively, than in wild-type littermates. These data show that the reduction of HDL-C levels in heterozygotes is almost completely due to decreased HDL-CE and apo A-I TRs.
apo B and apo A-I protein and mRNA levels in heterozygotes. The effects of one null apo B allele on plasma B-100, B-48, and apo A-I levels were analyzed by quantitative Western blot analysis. As shown in Fig. 6 A, in heterozygous apo B knockout mice B-100 was reduced 70%, B-48 50%, and apo A-I 40% compared with wild-type littermates. Northern blot analysis revealed heterozygotes had a 50% decrease in apo B mRNA levels in both liver and intestine compared with wildtype littermates, but neither tissue showed a decrease in apo A-I mRNA levels (Fig. 6, B and C) . These data suggest that the apo B gene dosage effect on plasma apo B levels is mainly transcriptional, whereas the decrease in plasma apo A-I in these mice is posttranscriptionally regulated.
Intestinal cholesterol absorption. To determine whether the decrease in intestinal apo B mRNA in heterozygotes diminished dietary cholesterol absorption, the double isotope method was used (31) . Mice were dosed intragastrically with '4C-cholesterol and intravenously with 3H-cholesterol. The percentage of cholesterol absorption through the intestine was then assessed by the isotope ratio ('4C/3H) present in the plasma (31 ) . Previous studies in both rats (31) and mice (32) Diet responsiveness in heterozygotes. Chronic feeding of a high fat diet increases plasma cholesterol levels. To determine whether responsiveness to diet is altered in the presence of a defective apo B allele, heterozygous apo B knockout mice and wild-type littermates were challenged for 2 wk with a Westerntype diet containing 21% fat and 0.15% cholesterol (23 ). In the fasting state, plasma triglyceride levels were not significantly increased on the high fat compared with the chow diet in either the heterozygous or wild-type littermates (Table III) . Compared with chow, the high fat diet significantly increased total cholesterol, VLDL-C, LDL-C, and HDL-C levels in heterozygous mice 86, 217, 60, and 68%, respectively, and wild-type mice 76, 188, 50, and 66%, respectively. Thus, both groups of mice responded similarly to a high fat diet and we conclude that the presence of a defective apo B allele does not alter diet responsiveness in the mouse.
Discussion
Gene targeting in ES cells was used to create mice with a null apo B allele. There were no live-born pups homozygous for the null allele, with death in utero occurring before day 9. There was also a decreased frequency of live-born heterozygotes with . apo B and apo A-I protein and mRNA levels in heterozygotes and wild-type littermates. Western blot analysis (A) was used to detect plasma apo B (top) and apo A-I (bottom). Plasma samples from both heterozygotes and wild-type littermates were subjected to a 5 or 10% SDS-PAGE for apo B or apo A-I detection, respectively, and then transferred to nitrocellulose membranes. Rabbit anti-rat apo B and antimouse apo A-I polyclonal antibodies were used to detect mouse apo B and apo A-I, respectively. The band between B-100 and B-48 resulted from nonspecific binding (NS) to the antibody and was not present when a different antibody was used. apo B genotypes for the animals are shown above each lane: + / + for wild-type mice and + / -for heterozygous knockouts. Northern blot analysis was used to detect apo B (top) and apo A-I (bottom) mRNA in liver (B) and small intestine (C). The amount of 63-actin mRNA was used as an RNA loading control.
some embryos shown to have severe neural tube defects by days 10-15 of gestation. Although most live-born heterozygotes were phenotypically normal, some were hydrocephalic. The clinical literature on patients with abetalipoproteinemia and homozygous hypobetalipoproteinemia does not describe fetal wastage or neural tube defects, therefore, the findings in the induced mutant mice were surprising. Since all heterozygous mice were derived from a single clone of ES cells, it is possible that another mutation accounting for the developmental abnormalities occurred during recombination in the creation of the null apo B allele. However, this is unlikely since a previous study using apo B gene targeting produced mutant mice that had decreased amounts of a truncated protein, B-70, also associated with developmental abnormalities (33) . In that study onethird of B-70 homozygotes and a small number of B-70 hetero- (1, 14) . Vitamin E deficiency is a potential cause of the developmental abnormalities observed, since exencephalus and hydrocephalus have been seen in offspring of vitamin E-deficient mothers (36, 37) . Vitamin A deficiency is less likely because, although vitamin A regulates the expression of many genes (38) , vitamin A-deficient mothers produce offspring that exhibit mainly ocular problems and gonad malformations, rather than neural tube defects (39) . In addition to defects in the central nervous system, infertility was observed in the majority of the male heterozygotes, whereas this was not present in female heterozygotes. Sterile male heterozygotes showed no gross abnormalities of the genitourinary system and normal appearing sperm were present in the epididymis (data not shown). Functional abnormality of the sperm may contribute to the infertility phenotype in these animals (Huang, L.-S., E. Voyiaziakis, H. L. Chen, E. M. Rubin, and J. W. Gordon, manuscript in preparation). Fertility has not been raised as an issue in humans with low levels of LDL; however, it cannot be ruled out as systematic studies of this issue have never been carried out. The mechanism whereby plasma levels of apo B or LDL-C might be linked to fertility remains obscure.
Mice heterozygous for a null apo B allele have major abnormalities in their lipoprotein transport system. Although triglyceride levels were unaffected, compared with wild-type mice heterozygotes had decreased total, LDL-C, and HDL-C levels on both chow and high fat diets. Although the B-70 mice mentioned above had a similar lipoprotein pattern, this was somewhat of a surprise since humans with heterozygous hypobetalipoproteinemia have decreased triglycerides and decreased total, VLDL-C, and LDL-C but have not been found to have consistently low HDL-C levels (1, 14) . In some kindred, HDL-C is clearly normal and in others it is even elevated. In the mice the metabolic basis for the reduced LDL-C is presumably reduced synthesis of apo B-containing lipoprotein particles as reflected by the decreased apo B mRNA levels in both liver and intestine. Turnover studies indicated that the metabolic basis for the reduced HDL in the heterozygous apo B knockout mice was decreased HDL-CE and apo A-I transport rates. This suggests that reduced apo B synthesis leads to diminished flux of cholesterol ester through the HDL pool. Perhaps reduced numbers of apo B-containing particles cause decreased delivery of cholesterol to peripheral tissues and this diminishes the need for reverse transport of cholesterol from peripheral tissues to the liver via HDL. Alternatively, there could be a decrease in the flux of hepatic-derived cholesterol ester into the HDL pool. It appears that reduced apo B synthesis also decreases apo A-I synthesis posttranscriptionally, as the levels of apo A-I mRNA do not change in liver and intestine. However, it is also possible that a rapidly turning over pool of nascent HDL was inadequately labeled in our study with a resulting apparent decrease in apo A-I synthesis. We have previously reported decreased apo A-I transport in mice and humans switched from high to low fat diets and in mice treated with probucol (25, 40, 41) . Mechanistic studies in the mice revealed decreased hepatic synthesis without a change in hepatic or intestinal mRNA levels as in the heterozygous apo B knockout mice. It is conceivable that in all three cases fat flux through the liver is decreased, which might decrease apo A-I synthesis by affecting liver apo A-I mRNA translation or degradation of newly synthesized apo A-I. apo B is a logical candidate gene to play a role in diet responsiveness. apo B synthesis is required for long chain fatty acid absorption by the intestine and apo B deficiency in humans prevents the formation of intestinal chylomicrons and hepatic VLDL (1) . Mice heterozygous for an apo B null allele with decreased intestinal and liver apo B mRNA provide a model to test whether half-normal levels of apo B synthesis influence diet responsiveness. Heterozygous mice did not fail to thrive nor did they have steattorrhea. They also had normal cholesterol absorption, and when switched from a low fat, low cholesterol, chow diet to a high fat, high cholesterol, Western-type diet they showed the same percent increase in total, VLDL, LDL, and HDL cholesterol levels as wild-type mice. Diet responsiveness and cholesterol absorption have never been studied in humans (15) were derived from intercrosses between F1 heterozygotes and contained equal amounts of genetic background from both parental strains. In contrast, the mice reported here were derived from backcrosses and contained more genetic materials from the C57BL/6J strain. The second is that different targeting vectors were used in these reports. Farese et al. (15) used an insertion vector to disrupt the apo B gene in intron 4, whereas a replacement vector was used to delete the first three exons of the apo B gene in this report. The presence of the first four exons might allow translation of an extremely small truncated apo B protein which could be functional. It has also been shown that repair processes are more likely to occur in the insertion vector-targeted genes during the recombination event than in the replacement vectortargeted genes (42) . In addition, we found that reduced apo B production did not affect intestinal cholesterol absorption and/ or the responsiveness to high fat challenge in heterozygous animals. In the report by Farese et al. ( 15 ) , heterozygotes were resistant to diet-induced hypercholesterolemia. We speculate that the observed differences were mainly due to differences in the components of the diet used by each group.
In summary, we have created a knockout mouse model to study the role of apo B in the body and have identified a number of possible functions for this apolipoprotein not suspected based on previous studies of apo B-deficient humans. apo B may play a role in fetal nutrition and may be required for embryonic development, specifically for neural tube closure. apo B may also be involved in male fertility. Reduced apo B production may also influence HDL-C levels by decreasing HDL-CE and apo A-I transport. Somewhat contrary to expectations, we also found that decreased apo B production did not diminish cholesterol absorption or alter diet responsiveness. The apo B knockout mouse model provides a system to explore the mechanisms underlying these postulated new functions of apo B.
